Published in Lab Law Weekly, April 10th, 2009
International, Inc. ("Relsys"), a leading provider of drug safety and
risk management solutions with advanced analytics for the health
sciences industry. -- Relsys' best-in-class solutions support adverse event reporting, risk
management, and data analysis for pharmaceutical, biotechnology,
contract research organizations and medical device companies
worldwide. -- The combination of Oracle and Relsys is expected to deliver the only
suite of software applications that supports...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2009-04-10)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.